• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Examining the paradoxical effects of kratom: a narrative inquiry.审视 kratom 的矛盾效应:一项叙事探究。
Front Pharmacol. 2023 May 5;14:1174139. doi: 10.3389/fphar.2023.1174139. eCollection 2023.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys.kratom带来的成长烦恼:在论坛上讨论的经历与调查中表达的满意度形成对比。
Front Pharmacol. 2024 Jun 14;15:1412397. doi: 10.3389/fphar.2024.1412397. eCollection 2024.
4
Assessment of Kratom Use Disorder and Withdrawal Among an Online Convenience Sample of US Adults.评估美国成年人在线便利样本中使用卡痛和戒断情况。
J Addict Med. 2022;16(6):666-670. doi: 10.1097/ADM.0000000000000986.
5
Novel methods for the remote investigation of emerging substances: Application to kratom.新兴物质的远程调查新方法:在恰特草中的应用。
Exp Clin Psychopharmacol. 2024 Apr;32(2):215-227. doi: 10.1037/pha0000656. Epub 2023 May 22.
6
Kratom: A growing substance of abuse in the United States.**译文**:**Kratom(咔特):美国不断增长的滥用物质。** **解析**:原文中“Kratom”是一种植物,常被加工成粉末或制成胶囊,在一些国家被用作草药或药物。然而,在美国,Kratom 被视为一种新兴的滥用物质,因为它具有致瘾性和潜在的毒性。
Ann Clin Psychiatry. 2020 Nov;32(4):275-280. doi: 10.12788/acp.0012.
7
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories.寻找信号:有定期使用 kratom 历史的美国成年人样本中自我报告的 kratom 剂量 - 效应关系。
Front Pharmacol. 2022 Mar 1;13:765917. doi: 10.3389/fphar.2022.765917. eCollection 2022.
8
Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy.kratom生物碱、大麻素与慢性疼痛:潜在效用基础及在治疗中的作用
Cannabis Cannabinoid Res. 2025 Apr;10(2):187-199. doi: 10.1089/can.2023.0064. Epub 2023 Jul 19.
9
Health Effects Associated With Kratom () and Polysubstance Use: A Narrative Review.与 kratom()及多物质使用相关的健康影响:一篇叙述性综述。
Subst Abuse. 2022 May 20;16:11782218221095873. doi: 10.1177/11782218221095873. eCollection 2022.
10
Kratom policy: The challenge of balancing therapeutic potential with public safety.**译文**:**Kratom** 政策:平衡治疗潜力与公共安全的挑战。
Int J Drug Policy. 2019 Aug;70:70-77. doi: 10.1016/j.drugpo.2019.05.003. Epub 2019 May 16.

引用本文的文献

1
Kratom use among ethnobotanical tea bar patrons in Colorado: Subjective drug effects, adverse reactions, and perceived benefits of use.科罗拉多州民族植物茶馆顾客中使用 kratom 的情况:主观药物效应、不良反应及使用的感知益处。
Drug Alcohol Depend Rep. 2025 Jul 12;16:100361. doi: 10.1016/j.dadr.2025.100361. eCollection 2025 Sep.
2
De facto opioids: Characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing.事实上的阿片类药物:新型7-羟基帽柱木碱和帽柱木碱假吲哚产品营销的特征
Drug Alcohol Depend. 2025 Jul 1;272:112701. doi: 10.1016/j.drugalcdep.2025.112701. Epub 2025 May 8.
3
An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans.单次给予人米托蒽醌后安全性概况及神经认知功能的探索性研究。 (注:原文中药物名称可能有误,正确的应该是米托坦“mitotane”,这里按照你提供的“mitragynine”翻译)
Psychopharmacology (Berl). 2025 Jun;242(6):1363-1376. doi: 10.1007/s00213-024-06734-2. Epub 2024 Dec 26.
4
Kratom (Mitragyna speciosa) use for self-management of pain: Insights from cross-sectional and ecological momentary assessment data.用于疼痛自我管理的 kratom(帽柱木属):来自横断面和生态瞬时评估数据的见解。
J Pain. 2025 Jan;26:104726. doi: 10.1016/j.jpain.2024.104726. Epub 2024 Nov 4.
5
Time course of kratom effects via ecological momentary assessment, by product type, dose amount, and assayed alkaloid content.通过产品类型、剂量和分析生物碱含量的生态瞬时评估来研究冰毒的作用时间过程。
Drug Alcohol Depend. 2024 Nov 1;264:112460. doi: 10.1016/j.drugalcdep.2024.112460. Epub 2024 Oct 10.
6
Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder.阿片类物质使用障碍评估、诊断和治疗的争议。
Curr Psychiatry Rep. 2024 Sep;26(9):487-496. doi: 10.1007/s11920-024-01524-1. Epub 2024 Aug 13.
7
[Kratom-From natural remedy to addictive drug and back].[ kratom——从天然药物到成瘾性药物再回归]
Nervenarzt. 2024 Sep;95(9):824-829. doi: 10.1007/s00115-024-01721-6. Epub 2024 Jul 31.
8
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys.kratom带来的成长烦恼:在论坛上讨论的经历与调查中表达的满意度形成对比。
Front Pharmacol. 2024 Jun 14;15:1412397. doi: 10.3389/fphar.2024.1412397. eCollection 2024.
9
Kratom safety and toxicology in the public health context: research needs to better inform regulation.公共卫生背景下的 kratom 安全性与毒理学:需要开展研究以更好地为监管提供依据。
Front Pharmacol. 2024 Jun 3;15:1403140. doi: 10.3389/fphar.2024.1403140. eCollection 2024.
10
Commentary: Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report.评论:阿片类药物过量死亡中是否存在 kratom:验尸官尸检毒理学报告的结果
Front Psychiatry. 2024 May 23;15:1411964. doi: 10.3389/fpsyt.2024.1411964. eCollection 2024.

本文引用的文献

1
Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey.横断面调查中,麻古(Mitragyna speciosa Korth.)使用行为与精神状况的相关性。
Exp Clin Psychopharmacol. 2023 Oct;31(5):963-977. doi: 10.1037/pha0000632. Epub 2023 Jan 12.
2
Kratom Alkaloids: A Blueprint?**植物碱**:蓝图?
ACS Chem Neurosci. 2023 Jan 18;14(2):195-197. doi: 10.1021/acschemneuro.2c00704. Epub 2023 Jan 3.
3
For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic.无论好坏:因新冠疫情导致的 kratom 和其他物质使用的自我报告变化。
Subst Abuse. 2022 Sep 28;16:11782218221123977. doi: 10.1177/11782218221123977. eCollection 2022.
4
Peripheral blood mononuclear cell microRNAs are novel biomarkers for diagnosing and monitoring Crohn's disease.外周血单个核细胞 microRNAs 是诊断和监测克罗恩病的新型生物标志物。
FASEB J. 2022 Oct;36(10):e22549. doi: 10.1096/fj.202200452R.
5
Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom.公众对 FDA 关于调整卡痛类物质时间表影响调查的回应的定性内容分析。
Int J Drug Policy. 2022 Oct;108:103817. doi: 10.1016/j.drugpo.2022.103817. Epub 2022 Aug 8.
6
Kratom use as more than a "self-treatment".使用咔哇潮饮作为“自我治疗”。
Am J Drug Alcohol Abuse. 2022 Nov 2;48(6):684-694. doi: 10.1080/00952990.2022.2083967. Epub 2022 Jun 29.
7
Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance.不同光照条件下,植物生长和植物碱合成在 [Kratom(Mitragyna speciosa (Korth.))]中的变化。
PLoS One. 2022 Apr 26;17(4):e0259326. doi: 10.1371/journal.pone.0259326. eCollection 2022.
8
Exploring the self-reported motivations of kratom ( Korth.) use: a cross-sectional investigation.探索 kratom(Korth.)使用的自我报告动机:一项横断面调查。
Am J Drug Alcohol Abuse. 2022 Jul 4;48(4):433-444. doi: 10.1080/00952990.2022.2041026. Epub 2022 Apr 7.
9
In vitro and in vivo pharmacology of kratom.**中文译文**:**咔哇**的体外和体内药理学。
Adv Pharmacol. 2022;93:35-76. doi: 10.1016/bs.apha.2021.10.001. Epub 2021 Dec 13.
10
Clinical Pharmacokinetic Assessment of Kratom (), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants.对具有阿片样作用的植物产品 kratom()在健康成年参与者中的临床药代动力学评估。
Pharmaceutics. 2022 Mar 11;14(3):620. doi: 10.3390/pharmaceutics14030620.

审视 kratom 的矛盾效应:一项叙事探究。

Examining the paradoxical effects of kratom: a narrative inquiry.

作者信息

Smith Kirsten E, Feldman Jeffrey D, Dunn Kelly E, McCurdy Christopher R, Weiss Stephanie T, Grundmann Oliver, Garcia-Romeu Albert, Nichels Janeen, Epstein David H

机构信息

Real-World Assessment, Prediction, and Treatment Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, United States.

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

出版信息

Front Pharmacol. 2023 May 5;14:1174139. doi: 10.3389/fphar.2023.1174139. eCollection 2023.

DOI:10.3389/fphar.2023.1174139
PMID:37214465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10196254/
Abstract

Surveys and case reports have documented kratom use in the United States (US) for over a decade. However, those reports have generally not examined in depth the role kratom plays in the lives of those who use it regularly for sustained periods. Until there are controlled studies of the pharmacology and subjective effects of kratom alkaloids in humans, one of the best sources of insight on kratom-product use remains qualitative data with nuanced descriptions of kratom effects from those who use it regularly. We conducted semistructured qualitative interviews with adults who regularly use kratom products, as part of a laboratory study of kratom-product self-administration. This qualitative component of the study was conducted as a narrative case-report series ( = 10). Despite some differences among participants, all experienced acute combination effects that were largely, even simultaneously, analgesic and stimulatory. Most participants had decreased their dosages over time, and one planned to quit. Five of the 10 participants met DSM-5-based criteria for kratom-use disorder (3 mild, 1 moderate, 1 severe, by symptoms counts). When kratom was inadvertently taken in larger than intended doses, participants described a constellation of symptoms that they called "the wobbles" (a jittery feeling accompanied by what seemed to be nystagmus); this was rare, but could be of scientific and clinical interest as a possible manifestation of serotonin syndrome. Most participants described tolerance but considered kratom generally safe at low-moderate doses, providing perceived benefits with less potential risk for adverse effects compared to pharmaceuticals or illicit drugs. In-depth interview data like these help confirm and clarify findings from larger survey studies and clinician-driven case reports. They are needed to inform the policy practice regarding kratom and may also help inform future experimental designs.

摘要

调查和病例报告显示,在美国,人们使用 kratom 已有十多年历史。然而,这些报告通常并未深入研究 kratom 在长期经常使用它的人群生活中所起的作用。在对 kratom 生物碱在人体中的药理学和主观效应进行对照研究之前,了解 kratom 产品使用情况的最佳信息来源之一仍然是定性数据,这些数据来自经常使用 kratom 的人对其效果的细致描述。作为 kratom 产品自我给药实验室研究的一部分,我们对经常使用 kratom 产品的成年人进行了半结构化定性访谈。该研究的这一定性部分作为一个叙事性病例报告系列(n = 10)进行。尽管参与者之间存在一些差异,但所有人都经历了急性联合效应,这些效应在很大程度上甚至同时具有镇痛和刺激作用。随着时间的推移,大多数参与者减少了剂量,其中一人计划戒烟。10 名参与者中有 5 人符合基于《精神疾病诊断与统计手册》第 5 版(DSM - 5)的 kratom 使用障碍标准(根据症状计数,3 例轻度、1 例中度、1 例重度)。当 kratom 意外服用剂量大于预期时,参与者描述了一系列他们称之为“摇晃感”的症状(一种伴有似乎是眼球震颤的紧张感);这种情况很少见,但作为血清素综合征的一种可能表现,可能具有科学和临床研究价值。大多数参与者描述了耐受性,但认为 kratom 在低至中等剂量下总体安全,与药物或非法药物相比,它能带来明显益处且潜在不良反应风险较低。这样的深入访谈数据有助于证实和阐明大型调查研究以及临床医生主导的病例报告的结果。它们对于为有关 kratom 的政策实践提供信息是必要的,也可能有助于为未来的实验设计提供参考。